Skip to content

Managing Wounds With Allevyn Life in a Home Health Care Environment

A Randomized, Controlled Study of Allevyn Life in the Management of Wounds in Home Health Care

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02776800
Enrollment
0
Registered
2016-05-18
Start date
2016-08-31
Completion date
2017-10-31
Last updated
2017-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wounds and Injuries

Keywords

Wound, Surgical Wound, Trauma Wound, Home Health Care, Home Health Nurse, Pressure Ulcer, Diabetic Foot Ulcer, Venous Leg Ulcer, Arterial Ulcer, Wound Dehiscence, Open Wound

Brief summary

When elderly patients need help caring for wounds, physicians may refer patients to home health care providers. The home health provider sees the patient in the patient's home and assists the patient with wound care. Working with the patient's physician, the home health provider will use the appropriate wound covering (dressing or bandage) to cover the wound. The goal of the home health provider is to ensure that the wound stays clean and progresses toward closure. The home health provider will conduct in-home patient visits at appropriate intervals to assess the status of the wound. Extensive resources are required to see patients in their own homes. If a dressing could effectively manage wounds and allow longer time between in-home visits (without affecting patient safety or progress of the wound toward closure), then resources could be saved. Thus, newer dressings are designed for longer wear times, using advanced foam pads and adhesives that help keep the dressing in place. The hypothesis of this study is that the use of Allevyn Life will decrease the number of in-home visits by home health providers without sacrificing patient safety.

Interventions

DEVICEAllevyn Life
DEVICEFoam dressing with an integrated adhesive border

Foam dressing normally used by the home health agency

Sponsors

Smith & Nephew, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1\. The informed consent document must be read, signed, and dated by the subject or the subject's legally authorized representative before conducting any study procedures or exams. 2. Subjects sixty-five (65) years of age or older. Subjects may be of either sex and of any race. 3\. Willing and able to allow home health clinician to conduct all required study visits. 4\. The subject (or caregiver) must be able to follow instructions, including the ability to have regular contact with the home health clinician between study visits. 5\. Are covered by traditional Medicare. 6. Have a wound that is suitable for treatment with a foam dressing and can be appropriately covered by a single piece of ALLEVYN Life or the comparator dressing. 7\. At Screening, wound exudate must be moderate to heavy, as determined by the home health clinician. 8\. Target wound may be a trauma wound, chronic wound, or post-surgical wound. 9. Wound care is the primary reason for the home health clinician visits and determines the frequency of home health visits. Subjects may have other comorbidities, but these cannot be the determining factor in scheduling the frequency of the home health visits.

Exclusion criteria

1. Contraindications or hypersensitivity to the use of the study dressings or their components (e.g., adhesive) 2. Any wound that requires an additional covering (e.g., compression dressing, cast, etc.) over the study dressing that prevents daily visualization of the dressing under study. 3. Target wound that requires daily dressing changes due to topical wound treatment (e.g., daily applications of ointments, creams, etc.) 4. Target wound and dressing that cannot be visualized by the subject or subject's caregiver.

Design outcomes

Primary

MeasureTime frame
Number of home health clinician visits in each group60 days

Secondary

MeasureTime frame
Home health provider time on-site60 days
Total cost of each treatment group60 days
Number of visits required compared to number initially anticipated60 days
Assess the Cardiff Wound Impact Schedule60 days
Average dressing wear time60 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026